Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

clobazam 2.5 MG/ML Oral Suspension [Onfi]

Known as: Onfi 2.5 MG in 1 mL Oral Suspension, Onfi 2.5 MG per 1 ML Oral Suspension, CLOBAZAM 2.5 mg in 1 mL ORAL SUSPENSION [Onfi] 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
낸드 플래시는 차세대 저장매체로서 지속적인 용량 확대가 진행되고 있으나 속도 측면의 성능은 크게 향상되지 않고 있다. 특히 Legacy 낸드 플래시의 경우 컨트롤러 인터페이스 과정에서 병목현상이 발생하여 이를 완화하기 위해 ONFI… Expand
Review
2012
Review
2012
Clobazam was initially developed in the early 1970s as a nonsedative anxiolytic agent, and is currently available as adjunctive… Expand
  • table I
  • figure 1
  • figure 2
  • table III
2004
2004
Abstract The author discusses the initial-boundary value problem (ui)t=Δui+fi(u1,…,um) with u i | ∂Ω =0 and ui(x,0)=φi(x), i=1… Expand
  • figure 1
  • figure 3
  • figure 4
  • figure 5